<code id='901015BD82'></code><style id='901015BD82'></style>
    • <acronym id='901015BD82'></acronym>
      <center id='901015BD82'><center id='901015BD82'><tfoot id='901015BD82'></tfoot></center><abbr id='901015BD82'><dir id='901015BD82'><tfoot id='901015BD82'></tfoot><noframes id='901015BD82'>

    • <optgroup id='901015BD82'><strike id='901015BD82'><sup id='901015BD82'></sup></strike><code id='901015BD82'></code></optgroup>
        1. <b id='901015BD82'><label id='901015BD82'><select id='901015BD82'><dt id='901015BD82'><span id='901015BD82'></span></dt></select></label></b><u id='901015BD82'></u>
          <i id='901015BD82'><strike id='901015BD82'><tt id='901015BD82'><pre id='901015BD82'></pre></tt></strike></i>

          explore

          explore

          author:focus    Page View:4
          UnitedHealth Group
          UnitedHealth Group’s Optum will pay $3.3 billion total for the home health giant Amedisys. Jim Mone/AP

          Home health and hospice chain Amedisys has chosen a new corporate owner.

          Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

          advertisement

          Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          comprehensive

          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more
          UnitedHealth, in a surprise, takes aim at Steward’s physician group
          UnitedHealth, in a surprise, takes aim at Steward’s physician group

          AdobeUnitedHealthGrouphasgobbledupphysicianpracticesatanastoundingrate—roughly20,000lastyearalone.Mo

          read more
          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more

          Young boy dies in trial for Pfizer Duchenne gene therapy

          MarkLennihan/APAyoungboydiedinatrialforPfizer’sexperimentalgenetherapyforDuchennemusculardystrophy,t